The Cardiovascular Disease in Intermittent Claudication (CAVASIC) study investigated whether baseline high-sensitivity (hs)-cTnT was associated with increased risk of cardiovascular events and all-cause mortality in male patients with PAD [42]. This evidence concerns the gene TNNT2 and peripheral arterial disease.